XML 107 R94.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidating Financial Information (Statements of Cash Flows) (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by operating activities $ 341,329 $ 98,102
Cash flows from investing activities:    
Sale of investment securities 19,555 12,942
Maturities of investment securities 31,574 28,610
Purchase of investment securities (16,867) (44,222)
Proceeds from sale or liquidation of long-term investments 23,407 0
Purchase of long-term investments (5,238) 0
Investments in real estate ventures (3,858) (21,908)
Investments in real estate, net (679) (1,153)
Purchase of subsidiaries 0 (668)
Distributions from investments in real estate ventures 5,172 23,200
Increase in cash surrender value of life insurance policies (751) (789)
Decrease in restricted assets 87 668
Investments in subsidiaries 0 0
Capital expenditures (6,242) (6,320)
Pay downs of investment securities 415 545
Proceeds from sale of fixed assets 0 8
Net cash provided by (used in) investing activities 46,575 (9,087)
Cash flows from financing activities:    
Proceeds from issuance of debt 531 0
Deferred financing costs 0 (33)
Repayments of debt (172,467) (230,771)
Borrowings under revolver 130,641 172,224
Repayments on revolver (165,593) (169,727)
Capital contributions received 0 0
Intercompany dividends paid 0 0
Dividends and distributions on common stock (63,478) (118,748)
Distributions to non-controlling interest (448) (285)
Proceeds from issuance of Vector common stock 52,563 0
Other 5 0
Net cash used in financing activities (218,246) (347,340)
Net increase (decrease) in cash, cash equivalents and restricted cash 169,658 (258,325)
Cash, cash equivalents and restricted cash, beginning of period 379,476 591,729
Cash, cash equivalents and restricted cash, end of period 549,134 333,404
Consolidating Adjustments    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by operating activities (104,924) (139,356)
Cash flows from investing activities:    
Sale of investment securities 0 0
Maturities of investment securities 0 0
Purchase of investment securities 0 0
Proceeds from sale or liquidation of long-term investments 0  
Purchase of long-term investments 0  
Investments in real estate ventures 0 0
Investments in real estate, net 0 0
Purchase of subsidiaries   0
Distributions from investments in real estate ventures 0 0
Increase in cash surrender value of life insurance policies 0 0
Decrease in restricted assets 0 0
Investments in subsidiaries 9,164 27,482
Capital expenditures 0 0
Pay downs of investment securities 0 0
Proceeds from sale of fixed assets   0
Net cash provided by (used in) investing activities 9,164 27,482
Cash flows from financing activities:    
Proceeds from issuance of debt 0  
Deferred financing costs   0
Repayments of debt 0 0
Borrowings under revolver 0 0
Repayments on revolver 0 0
Capital contributions received (9,164) (27,482)
Intercompany dividends paid 104,924 139,356
Dividends and distributions on common stock 0 0
Distributions to non-controlling interest 0 0
Proceeds from issuance of Vector common stock 0  
Other 0  
Net cash used in financing activities 95,760 111,874
Net increase (decrease) in cash, cash equivalents and restricted cash 0 0
Cash, cash equivalents and restricted cash, beginning of period 0 0
Cash, cash equivalents and restricted cash, end of period 0 0
Parent/Issuer | Reportable Legal Entities    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by operating activities 126,021 78,661
Cash flows from investing activities:    
Sale of investment securities 19,555 12,942
Maturities of investment securities 31,574 28,610
Purchase of investment securities (16,867) (44,222)
Proceeds from sale or liquidation of long-term investments 23,407  
Purchase of long-term investments (5,238)  
Investments in real estate ventures 0 0
Investments in real estate, net 0 0
Purchase of subsidiaries   0
Distributions from investments in real estate ventures 0 0
Increase in cash surrender value of life insurance policies (340) (385)
Decrease in restricted assets (13) (15)
Investments in subsidiaries (9,164) (27,482)
Capital expenditures (20) 0
Pay downs of investment securities 415 545
Proceeds from sale of fixed assets   0
Net cash provided by (used in) investing activities 43,309 (30,007)
Cash flows from financing activities:    
Proceeds from issuance of debt 0  
Deferred financing costs   0
Repayments of debt (169,610) (230,000)
Borrowings under revolver 0 0
Repayments on revolver 0 0
Capital contributions received 0 0
Intercompany dividends paid 0 0
Dividends and distributions on common stock (63,478) (118,748)
Distributions to non-controlling interest 0 0
Proceeds from issuance of Vector common stock 52,563  
Other 80  
Net cash used in financing activities (180,445) (348,748)
Net increase (decrease) in cash, cash equivalents and restricted cash (11,115) (300,094)
Cash, cash equivalents and restricted cash, beginning of period 272,282 474,880
Cash, cash equivalents and restricted cash, end of period 261,167 174,786
Subsidiary Guarantors | Reportable Legal Entities    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by operating activities 325,721 148,639
Cash flows from investing activities:    
Sale of investment securities 0 0
Maturities of investment securities 0 0
Purchase of investment securities 0 0
Proceeds from sale or liquidation of long-term investments 0  
Purchase of long-term investments 0  
Investments in real estate ventures 0 0
Investments in real estate, net 0 0
Purchase of subsidiaries   0
Distributions from investments in real estate ventures 0 0
Increase in cash surrender value of life insurance policies (411) (404)
Decrease in restricted assets 100 683
Investments in subsidiaries 0 0
Capital expenditures (2,973) (2,753)
Pay downs of investment securities 0 0
Proceeds from sale of fixed assets   8
Net cash provided by (used in) investing activities (3,284) (2,466)
Cash flows from financing activities:    
Proceeds from issuance of debt 0  
Deferred financing costs   (33)
Repayments of debt (204) (621)
Borrowings under revolver 130,641 172,224
Repayments on revolver (165,593) (169,727)
Capital contributions received 550 575
Intercompany dividends paid (97,259) (102,739)
Dividends and distributions on common stock 0 0
Distributions to non-controlling interest 0 0
Proceeds from issuance of Vector common stock 0  
Other 0  
Net cash used in financing activities (131,865) (100,321)
Net increase (decrease) in cash, cash equivalents and restricted cash 190,572 45,852
Cash, cash equivalents and restricted cash, beginning of period 27,730 23,849
Cash, cash equivalents and restricted cash, end of period 218,302 69,701
Subsidiary Non-Guarantors | Reportable Legal Entities    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by operating activities (5,489) 10,158
Cash flows from investing activities:    
Sale of investment securities 0 0
Maturities of investment securities 0 0
Purchase of investment securities 0 0
Proceeds from sale or liquidation of long-term investments 0  
Purchase of long-term investments 0  
Investments in real estate ventures (3,858) (21,908)
Investments in real estate, net (679) (1,153)
Purchase of subsidiaries   (668)
Distributions from investments in real estate ventures 5,172 23,200
Increase in cash surrender value of life insurance policies 0 0
Decrease in restricted assets 0 0
Investments in subsidiaries 0 0
Capital expenditures (3,249) (3,567)
Pay downs of investment securities 0 0
Proceeds from sale of fixed assets   0
Net cash provided by (used in) investing activities (2,614) (4,096)
Cash flows from financing activities:    
Proceeds from issuance of debt 531  
Deferred financing costs   0
Repayments of debt (2,653) (150)
Borrowings under revolver 0 0
Repayments on revolver 0 0
Capital contributions received 8,614 26,907
Intercompany dividends paid (7,665) (36,617)
Dividends and distributions on common stock 0 0
Distributions to non-controlling interest (448) (285)
Proceeds from issuance of Vector common stock 0  
Other (75)  
Net cash used in financing activities (1,696) (10,145)
Net increase (decrease) in cash, cash equivalents and restricted cash (9,799) (4,083)
Cash, cash equivalents and restricted cash, beginning of period 79,464 93,000
Cash, cash equivalents and restricted cash, end of period $ 69,665 $ 88,917